NeMusangano Wepagore wechimakumi matatu nembiri weUrology Association (CUA) wava kuda kuitwa muDalian, ndiri kutanga patsva, ndichiongororazve ruzivo rwangu rwekare rweurological endoscopy. Mumakore angu ese eendoscope, handisati ndamboona dhipatimendi rimwe chete richipa akasiyana endoscopes akasiyana, anosanganisira optical, emagetsi, uye akasiyana zvirevo. Uyezve, urological endoscopes iri kukurumidza kubuda, uye mudzimba, vanopihwa mazita akashinga se "cannonscope" uye "ndege inotakura ndege." Chiitiko changu chekutanga navo chaishamisa. Ndakambonyora rondedzero yezvitarisiko uye mhando dzeanochinjika uye akaomarara endoscopes, ayo anoshanda seyakakosha kudzidza chiitiko chebasa rangu.
Munguva pfupi yapfuura, ndanga ndichidzidza urological endoscopy ine zero-based mentality. Ndichainyora maererano nenzvimbo yechirwere. Ndisati ndadzidza, ini ndichatanga ndanzwisisa imwe yakakosha data.
Data uye nhamba yekuvhiya inodiwa kune mamwe mamiriro eurological
Urology ikozvino yakakamurwa kuva yepamusoro weti turakiti (itsvo uye ureters), rezasi weti turakiti (dundira uye prostate), uye andrology. Uyezve, nehuwandu hwekuchembera, huwandu hwezvirwere zveurological hunotarisirwa kukwira. Kunobva data: Chidzidzo chakaburitswa muScientific Reports neUrology Team yeFirst Affiliated Hospital yeSoochow University yakaita ongororo yekutanga yakazara yehureme hwepasi rose hweBPH (benign prostatic hyperplasia) kubva muna 1990 kusvika 2021 zvichibva pane dhatabhesi yeGBD 2021. Ongororo yekuora yakasimbisa kuti 61% yekuwedzera kwepasirese kwenyaya kwakakonzerwa nekuchembera kwevanhu, 29% kusvika pakukura kwevanhu, uye 10% kune epidemiological shanduko.
Kubva mukupera kwa2024, huwandu hwevanhu veChina vane makore makumi matanhatu zvichikwira hwasvika 310.31 miriyoni (vanosvika 310 miriyoni), vachiverengera 22.0% yehuwandu hwevanhu; pakati pavo, huwandu hwevanhu vane makore 65 uye pamusoro ndeye 220.23 mamiriyoni (anenge mamiriyoni 220), anoverengera 15,6% yevanhu vose.
Kenza yeprostate (CA): Yakaiswa pekutanga pakati pegomarara reurinary tract, ine chiitiko che 13.42 pa100,000 vanhu. Zvichienderana neguta rine huwandu hwevanhu mamirioni mashanu, kune mazana matanhatu nemakumi manomwe nenomwe zviitiko pagore. Zvinoenderana neongororo ya2025 "Prostate Cancer Epidemiological Trends, Genomic Characteristics, uye Remangwana Mafambiro eOptimized Management muChina," vangangosvika makumi mashanu neshanu muzana evarwere munyika yangu vane metastases kure panguva yekutanga kuongororwa. Nokudaro, nhamba yevarwere vane zviratidzo zvekuvhiya inenge 671 * 0.46 = 308.
Gomarara redundiro: Chiyero chechiitiko i9.29 pa100,000 vanhu, ine gore rega rega kese chiyero chevanhu vangangoita mazana mana nemakumi matanhatu neshanu muguta rine huwandu hwevanhu 5 miriyoni. Kubva pane data yepaIndaneti, kutora 75% NMIBC (Tis, Ta, T1) chiyero, nhamba yegore yezviitiko zvitsva zvine zviratidzo zvekuvhiya ndeye 348. Laparoscopic renal cancer: Chiitiko chechiitiko ndeye 7.37 kune 100,000 vanhu, ine gore negore itsva yemhosva inenge 368 muguta rine vanhu vane mamiriyoni e5. Kubva pane maitiro ezvirwere zve "Kudzidza Kwemakore Gumi pamusoro peKubatana pakati peKuvhiya Maitiro uye Clinicopathological Characteristics yeRenal Cell Carcinoma" yakabudiswa nePeking University First Hospital, pT1 danho rinotora 79.6%, zvichiita kuti inofungidzirwa kuvhiyiwa kunoratidza inenge 293. Laparoscopic benign prostatic data pamusoro, ne2B, will be0 (2) 310.31 miriyoni vanhu munyika yangu vane makore makumi matanhatu zvichikwira, vanoverengera 22.03% yehuwandu, avo vangangoita 48.73% varume (huyai, varume, hamusi kurarama kwenguva yakareba sevakadzi). Kuitika kweBPH kune vane makore makumi matanhatu zvichikwira i50%, iyo gumi muzana inoda kuvhiyiwa. Huwandu hwevanhu vanoda kurapwa kweBPH muguta rine vanhu vanosvika mamiriyoni mashanu ndeichi: 5 miriyoni * 22.03% * 48.73% * 50% * 10% ≈ 26,838 vanhu, izvo zvakawanda chaizvo.
Urinary matombo: Iko hakuna data yepamutemo iripo. Kubva pa5% chiitiko chechiitiko, 25% inoda kurapwa kwekuvhiya. Muguta rine huwandu hwevanhu vanosvika 5 miriyoni, chiitiko chegore negore uye kurapwa zvinenge 62,500, izvo zvakawandisa. Zvechokwadi, iyi ndiyo muganhu wepamusoro. Extracorporeal lithotripsy, ureteroscopic laser lithotripsy, uye percutaneous nephrolithotomy ine pneumatic (laser) lithotripsy inoshandiswa.
Kubva kumusoro kusvika kuzasi nenzvimbo yeanatomical
Percutaneous nephrolithotomy
Percutaneous nephrolithotomy (PCNL) inzira ishoma inopinza inogadzira chiteshi kuburikidza neganda kurapa matombo eitsvo kana maronda. Inonyanya kushandiswa kurapa hombe (> 2 cm) kana yakaoma itsvo matombo. Yayo yakakosha mabhenefiti ari mukushungurudzika kushoma, kukurumidza kupora, uye yakakwirira matombo-kucheneswa mitengo. Nephroscopes iri kuramba ichiva diki mudhayamita, ine migero yakajairika (24-30 Fr), microchannels (16-22 Fr), uye ultrafine chiteshi (<16 Fr). Zviridzwa zvetsotripsy zvakaumbwa netsono zvine madhayamita anenge 1.4 mm zvave kuwanikwawo. Percutaneous nephrolithotomy midziyo yakajairwa muurological lithotripsy centers.
Iyo percutaneous nephrroscope ine munda wekuona 12 °, elliptical sheath, kunze kwedhayamita ye8.5 Fr / 12 Fr, inobudirira yekushanda yakareba inenge 250 mm, uye nzira yekushanda inenge 6 Fr.
Isu, Jiangxi Zhuoruihua Medical Instrument Co., Ltd., inogadzira muChina inyanzvi mune endoscopic consumables, inosanganisira GI mutsara senge biopsy forceps, hemoclip, polyp musungo, sclerotherapy tsono, pfapfaidzo catheter, cytology mabhurashi, gwara, dombo rekudzoreredza bhasikiti rinoshandiswa mubhasikiti rakafara. EMR, ESD, ERCP. Uye Urology Line, sengeureral access sheath nekuyamwauyeureral access sheath,inoraswa Urinary Stone Retrieval Basket,uyeurology guidewireetc.
Zvigadzirwa zvedu ndezveEC Certified, uye zvidyarwa zvedu ISO certified. Zvinhu zvedu zvakatumirwa kuEurope, North America, Middle East uye chikamu cheAsia, uye zvakanyanya kuwana mutengi wekuzivikanwa nekurumbidzwa!
Nguva yekutumira: Sep-22-2025